Total AssetsThose who like to short got liquidated $Hims & Hers Health(HIMS.US)$Defiance Daily Target 2X Long HIMS ETF(HIMZ.US)
$Hims & Hers Health(HIMS.US)
Drug price cuts are favorable for Hims & Hers Health, which primarily deals with generic drugs. No matter how much prices drop, they can't compete with the low prices of generics. Moreover, Hims is not a drug manufacturer but a service provider. The lower the prices, the greater the user retention. This is actually negative for Eli Lilly and Novo Nordisk.
All-in on calls, targeting $50 $Hims & Hers Health(HIMS.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
